 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > BioWhittaker, Inc.
 |
BioWhittaker, Inc. |
 |
 |
 |
PROFILE |
 |
Gee whillikers! BioWhittaker, acquired in 1997 as the biotechnology division of specialty chemical firm Cambrex, is a leading supplier of cell cultures (living cells grown in an artificial environment) used for research and detection of viruses and diseases. Products include animal tissue extracts, dyes, stains, enzymes, and bacterial media. The company also offers endotoxin-detection products that test implantable and injectable medical devices for dangerous contamination. In addition to the US market, BioWhittaker sells its products directly to customers in Europe and the US and through distributors elsewhere around the world. Clients are commercial, government, and university labs.
COMPETITION |
 |
Becton, Dickinson and Company (BDX)
Fisher Scientific International Inc. (FSH)
Invitrogen Corporation (IVGN)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
1999 Sales (mil.): 83.90
1-Yr. Sales Growth: 27.2%
Employees: 450
Revenue per employee: $186,444.44
KEY PEOPLE |
 |
Mark Haggeman
CFO
CONTACT INFO |
 |
8830 Biggs Ford Rd.
Walkersville, MD 21793
US
Phone: 301-898-7025
Fax: 301-845-4024
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |